Switching to single-use bioreactors can have financial and performance benefits.
Jean-François Chaubard
Advertisement
Jean-François Chaubard is a director at Viral Industrial Bulk, GSK Biologicals
Articles by Jean-François Chaubard
Advertisement
Latest Updated Articles
Disposable Bioreactors for Viral Vaccine Production: Challenges and OpportunitiesPublished: November 2nd 2010 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Industry Leaders Detail Transformational Strategies to Mainstream CAR-T Care
2
Why Flexibility and Commercial Viability Must Be Built-in Early for Scaling CGTs
3
Analyzing the Safety and Scope of Next-Generation Gene Editing Platforms
4
How Rentschler Biopharma’s New Platforms Aim to Accelerate Biologics Development in Asia
5
